| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/2013 | EP2399580B1 Pharmaceutical dosage forms |
| 04/03/2013 | EP2399579B1 Pharmaceutical dosage forms |
| 04/03/2013 | CN1989244B Inhibitors of tgf-r signaling for treatment of cns disorders |
| 04/03/2013 | CN1972676B Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 04/03/2013 | CN1921863B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions |
| 04/03/2013 | CN1846690B Emulsion medicine injection of propofol and preparation process thereof |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN103025873A Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
| 04/03/2013 | CN103025750A VEGF production promoter |
| 04/03/2013 | CN103025749A Polymorphs of 2'-o-fucosyllactose and producing thereof |
| 04/03/2013 | CN103025744A Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs |
| 04/03/2013 | CN103025741A Crystalline forms of kinase inhibitors |
| 04/03/2013 | CN103025740A Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
| 04/03/2013 | CN103025738A Furopyridine compounds and uses thereof |
| 04/03/2013 | CN103025736A Macrocyclic hepatitis c serine protease inhibitors |
| 04/03/2013 | CN103025732A Cis-tetrahydrospiro(cyclohexane-1,1'-pyrido[3,4-b]indol)-4-amine derivatives |
| 04/03/2013 | CN103025731A 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 04/03/2013 | CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 04/03/2013 | CN103025727A Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof |
| 04/03/2013 | CN103025726A A substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 04/03/2013 | CN103025725A Hetero ring compound |
| 04/03/2013 | CN103025724A 哌啶衍生物 Piperidine derivatives |
| 04/03/2013 | CN103025722A Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity |
| 04/03/2013 | CN103025721A Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same |
| 04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
| 04/03/2013 | CN103025714A Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| 04/03/2013 | CN103025710A Process for the synthesis of isothiocyanates and derivatives thereof and uses of same |
| 04/03/2013 | CN103025707A Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases |
| 04/03/2013 | CN103025705A Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
| 04/03/2013 | CN103025383A Compounds for the treatment of clostridium difficile associated disease |
| 04/03/2013 | CN103025382A A method of managing broncho-constrictive condition |
| 04/03/2013 | CN103025353A Treatment methods |
| 04/03/2013 | CN103025340A Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 04/03/2013 | CN103025339A Expression modulator for clock gene Period |
| 04/03/2013 | CN103025338A Composition for improving condition of skin |
| 04/03/2013 | CN103025334A Anti-diabetic compositions and methods |
| 04/03/2013 | CN103025333A Compound, composition, and method for protecting skin from high energy visible light |
| 04/03/2013 | CN103025332A Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes |
| 04/03/2013 | CN103025331A Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 04/03/2013 | CN103025330A Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
| 04/03/2013 | CN103025329A Association of xanthine oxidase inhibitors and statins and use thereof |
| 04/03/2013 | CN103025328A Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications |
| 04/03/2013 | CN103025327A Oral iron deficiency therapy |
| 04/03/2013 | CN103025326A Methods of treating restless legs syndrome |
| 04/03/2013 | CN103025325A Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy |
| 04/03/2013 | CN103025324A Pharmaceutical composition with olive extract (hydroxytyrosol) and hop extract (xanthohumol) for intranasal application |
| 04/03/2013 | CN103025323A Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved |
| 04/03/2013 | CN103025321A Fast dissolving drug delivery systems |
| 04/03/2013 | CN103025320A Intravaginal drug delivery device |
| 04/03/2013 | CN103025317A Nalbuphine-based formulations and uses thereof |
| 04/03/2013 | CN103025312A 接触透镜药物递送装置 Contact lens drug delivery device |
| 04/03/2013 | CN103025306A Astaxanthin-containing aqueous composition, cosmetic preparation, and method for suppressing degradation of astaxanthin |
| 04/03/2013 | CN103025159A Novel methods for targeting cancer stem cells |
| 04/03/2013 | CN103012789A Preparation method of niacin sevelamer |
| 04/03/2013 | CN103012778A Water-soluble taxol polymer with tumor actively-targeted property |
| 04/03/2013 | CN103012671A Coumarin macromolecule polymer with anti-tumor activity and preparation method of coumarin macromolecule polymer |
| 04/03/2013 | CN103012621A High-purity heparin benzyl ester salt and preparation method and application thereof |
| 04/03/2013 | CN103012620A High-purity heparin benzyl ester salt and preparation method and application thereof |
| 04/03/2013 | CN103012540A 22-drop-6-hydroxystigmast-3,22-O-dimethyloxime ether and 22-drop-6-oximido-stigmast-3,22-O-dimethyloxime ether and application thereof to preparation of antitumor drugs |
| 04/03/2013 | CN103012537A Dammarane type triterpene compound and preparation method and application thereof |
| 04/03/2013 | CN103012530A Preparation method of compound endecaphyllacins B and application thereof in preparation of anti-tumor drugs |
| 04/03/2013 | CN103012523A Flavonoids separated from Qingkailing, and preparation method and application thereof |
| 04/03/2013 | CN103012520A Anti-HBV (Hepatitis B Virus) active compound philippine indican derivative |
| 04/03/2013 | CN103012513A Preparation method and application of methyl-hydroxyl stilbene glycoside crystal |
| 04/03/2013 | CN103012439A Benzoyl substituted thiazolo[3,2-b]-1,2,4-triazine derivative and application thereof |
| 04/03/2013 | CN103012438A Alkoxy substituted thiazolo [3,2-b]-1,2,4-triazine derivatives and application thereof |
| 04/03/2013 | CN103012434A Cefathiamidine compound crystal and preparation method as well as pharmaceutical composition thereof |
| 04/03/2013 | CN103012430A Mezlocillin sodium compound and medicine composition thereof |
| 04/03/2013 | CN103012429A Novel amoxicillin sodium compound and composition of amoxicillin sodium compound and sulbactam sodium compound |
| 04/03/2013 | CN103012428A 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
| 04/03/2013 | CN103012427A Prasugrel hydrochloride ethanol solvate and preparation method thereof |
| 04/03/2013 | CN103012421A Isoquinoline drug, its preparation and application |
| 04/03/2013 | CN103012420A Lycorine derivative, veterinary drug taking lycorine derivative as an active constituent, and applications of lycorine derivative |
| 04/03/2013 | CN103012417A Carbazole alkaloids in clausena plants, medicine composition with carbazole alkaloids as anti-tumor active component, and preparation method and application of carbazole alkaloids |
| 04/03/2013 | CN103012416A Method for preparing high-purity nalmefene hydrochloride |
| 04/03/2013 | CN103012410A [1,2,4] triazole [4,3-b] sym-tetrazine derivation compound and preparation method thereof |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012405A New adenine type compound |
| 04/03/2013 | CN103012404A Polymorphic substance of valganciclovir hydrochloride and medical composition thereof |
| 04/03/2013 | CN103012401A Preparation method and application of anthraquinone polypyridine ligand and ruthenium-anthraquinone complex |
| 04/03/2013 | CN103012399A 7-oxopyridinopyrimidine compound as well as medicinal composition and application thereof |
| 04/03/2013 | CN103012398A Imidazoquinoline derivative and medicinal salt thereof and preparation method and medical application thereof |
| 04/03/2013 | CN103012397A Pyrazolo quinolinone derivative and preparation method thereof as well as therapeutic application of derivative |
| 04/03/2013 | CN103012394A Rhodanine derivative and preparation method thereof |
| 04/03/2013 | CN103012390A Indole derivatives as S1P1 receptor |
| 04/03/2013 | CN103012381A Benzofuran compound, preparation method thereof and application of benzofuran compound in preparation of antiarrhythmic drugs |
| 04/03/2013 | CN103012380A Chroman compound, and preparation method and application thereof |
| 04/03/2013 | CN103012379A Phenylalanine derivatives, preparation method and application thereof |
| 04/03/2013 | CN103012376A Amide derivatives |
| 04/03/2013 | CN103012374A Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 04/03/2013 | CN103012373A Pantoprazole sodium compound and pharmaceutical composition thereof |
| 04/03/2013 | CN103012371A Omeprazole sodium crystalline compound, preparation method and medicine composition thereof |
| 04/03/2013 | CN103012369A Lansoprazole N crystal form and preparation method and application thereof |
| 04/03/2013 | CN103012368A Quinoline derivative |
| 04/03/2013 | CN103012367A Quinoline derivative |
| 04/03/2013 | CN103012359A (2's)-kadsura longepedunculata xylogen J and preparation method thereof |
| 04/03/2013 | CN103012358A Compound extracted from antrodia camphorate, medical composition containing compound and application of compound |
| 04/03/2013 | CN103012356A Compound with alpha-glycosidase inhibitory activity, as well as preparation method and application of compound |
| 04/03/2013 | CN103012349A Crystal form C of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 04/03/2013 | CN103012348A 6,8-substituted naringenin derivative and application thereof |